Engineered Pluripotent Mesenchymal Cells Integrate and Differentiate in Regenerating Bone: A Novel Cell-Mediated Gene Therapy

Journal of Gene Medicine

Volumn 1, Issue 2, 1999, Pages 121-133

  Gazit, Dan ^a   Turgeman, Gadi ^a   Kelley, Pamela ^b   Wang, Elizabeth ^b   Jalenak, Mary ^b   Zilberman, Yoram ^a   Moutsatsos, Ioannis ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b PFIZER INC   (United States)

Author keywords

BMP2; Bone regeneration; Cell mediated therapy; Gene therapy; Non union fractures; Pluripotent mesenchymal cells

Indexed keywords

BMP2 PROTEIN, HUMAN; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BONE; C3H MOUSE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; CHO CELL; CYTOLOGY; FEMALE; FRACTURE HEALING; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; MESODERM; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIUS FRACTURE; REGENERATION; STEM CELL;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; CHO CELLS; CRICETINAE; FEMALE; FRACTURE HEALING; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; MESODERM; MICE; MICE, INBRED C3H; MODELS, BIOLOGICAL; RADIUS FRACTURES; REGENERATION; STEM CELLS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033084785     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J     Document Type: Article

References (44)

1. Einhorn TA. Current concepts review: enhancement of fracture healing. J Bone Joint Surg 1995; 77: 940-956.
2. Mohan S, Baylink D. Therapeutic potential of TGF-β, BMP and FGF in the treatment of bone loss. In Principles of Bone Biology, In: Bilzikian JP, Raisz LG, Rodan GA (eds) Academic Press, 1996; Ch 80, 1111-1123.
3. Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991; 254: 1507-1509.
4. St. Louis D, Verma IM. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 1988; 85: 3150-3154.
5. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 1991; 254: 1509-1512.
6. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995; 374: 367-370.
7. Lacorazza HD, Flax JD, Snyder EY, Jendoubi M. Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med 1996; 2: 424-429.
8. Snyder EY, Park KI, Flask JD, Liu S, Rosario CM, Yandava BD, Aurora S. Potential of neural 'stem-like' cells for gene therapy and repair of the degenerating central nervous system. Adv Neurol 1997; 72: 121-132.
9. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kritz RW, Hewick RM, Wang EA. Novel regulation of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
10. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. The non-osteogenic mouse pluripotent cell line C3H10T1/2 is induced to differentaite into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990; 172: 295-299.
11. Chen P, Carrington JL, Hammonds RG, Reddi AH. Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2b (BMP-2b) and modulation by transforming growth factor-b1 and b2. Exp Cell Res 1991; 195: 509-515.
12. Theis RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992; 130: 1318-1324.
13. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993; 12: 871-880.
14. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993; 9: 57-71.
15. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994; 161: 218-228.
16. Rosen V, Nove J, Song JJ, Theis RS, Cox K, Wozney JM. Responsiveness of clonal limb bud cell line to bone morphogenetic protein 2 reveals sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 1994; 9: 1759-1768.
17. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effect of bone morphogenetic protein-2, -4, -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995; 136: 2671-2677.
18. Yamaguchi A. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-β superfamily. Semin Cell Biol 1995; 6: 165-173.
19. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Ketagiri T, Wozney JM, Rosen V, Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow drived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophysiol Res Comm 1996; 220: 366-371.
20. Balk ML, Bray J, Day C, Epperly M, Greenberger J, Evans CH, Niyibizi C. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Bone 1997; 21: 7-15.
21. Chaudhari A, Ron E, Rethman MP. Recombinant human bone morphogenetic protein-2 stimulate differentiation in primary cultures of fetal rat clavarial osteoblasts. Mol Cell Biochem 1997; 167: 31-39.
22. Hanada K, Dennis JE, Caplan AJ. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow derived mesenchymal stem cells. J Bone Miner Res 1997; 12: 1606-1614.
23. Puleo DA. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol 1997; 173: 93-101.
24. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990; 87: 2220-2224.
25. Volek-Smith H, Urist MR. Recombinant human bone morphogenetic protein (rhBMP) induces heterotopic bone development in vivo and in vitro. P.S.E.B.M. 1996; 211: 265-272.
26. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg 1991; 117: 1101-1112.
27. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg 1992; 74: 659-670.
28. Gerhart TN, Kirker CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH, Wang E. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Rel Res 1993; 293: 317-326.
29. Lee SC, Shea M, Battle MA, Koritza K, Rone E, Turek T, Schaub RG, Hayes WC. Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PGLA matrix. J Biomed Mater Res 1994; 28: 1149-1156.
30. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO. Osseous regeneration in rat clavarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 1994; 28: 1139-1147.
31. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG, Ron E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994; 28: 1127-1138.
32. Kirker-Head CA, Gerhart TN, Schelling SH, Hennig GE, Wang E, Holtrop ME. Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clin Orthop Rel Res 1995; 318: 222-230.
33. Linde A, Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in rats. Calcif Tissue Int 1995; 56: 549-553.
34. Boyne P. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 1996; 19: 83S-92S.
35. Kaufman RJ, Davies MV, Wasley LC, Michnick D. Improved vectors for stable expression of forign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res 1991; 19: 4485-4490.
36. Israel IE, Nove J, Kerns M, Moutsatsos IK. Expression of bone morphogenetic protein-2 in Chinese Hamster Ovary cells. Growth Factors 1992; 7: 139-150.
37. Gazit D, Zilberman Y, Turgeman G, Zhou S, Ebner R, Kahn A. Recombinant TGF-β1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 1999.
38. Pavlath GK, Rando TA, Blau HM. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 1994; 127: 1923-1932.
39. Durham J. Metabolism of fracture healing. Fracture Repair and Regeneration, Bone (volume 5). In In: Hall BKBoca Raton: CRC Press, 1992; Ch 1: 1-28.
40. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994; 126: 1595-1609.
41. Tessler A, Fischer I, Giszter S, Himes BT, Miya D, Mon F, Murray M. Embryonic spinal cord transplants enhance locomotor performance in spinalized newborn rats. Adv Neurol 1997; 72: 291-303.
42. Fang J, Zho Y, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996; 93: 5753-5758.
43. Lieberman JR, Le LQ, Wu L, Finerman GAM, Berk A, Witte ON, Stevenson S. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998; 16: 330-339.
44. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 1997; 100: 2824-2832.